DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo


25.11 1.72 (7.35%)

Quote as of

company name or ticker

Recent Quotes

INSM $25.11 7.35%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.90
Previous Close $23.39
Daily Range $23.46 - $25.15
52-Week Range $12.17 - $28.66
Market Cap $1.6B
P/E Ratio -12.38
Dividend (Yield) $0.00 (0.0%)
Volume 473,355
Average Daily Volume 435,578
Current FY EPS -$1.94




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Insmed's (INSM) CEO Will Lewis on Q2 2015 Results - Earnings Call Transcript

Insmed (INSM) Q2 2015 Results - Earnings Call Webcast

Stocks Hitting 52-Week Highs

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

See More INSM News...

INSM's Top Competitors

INSM $25.11 (7.35%)
Current stock: INSM
GILD $104.27 (2.74%)
Current stock: GILD
AMGN $152.29 (3.28%)
Current stock: AMGN
BIIB $304.21 (4.00%)
Current stock: BIIB